Legalized Marijuana: Uses, Misuses & Abuses. Disclosures. Objectives. Kennon Heard University of Colorado SOM Dept Of Emergency Medicine

Similar documents
A look at Marijuana in 2014

WHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis. Expert Peer Review 2

Cannabis. Member of the Cannabaceae family of flowering plants (along with hops) Cannabis sativa (v. sativa, indica, afghanica, ruderalis)

Consumer Information Cannabis (Marihuana, marijuana)

Medical Marijuana. 1. is a plant species, variety known as hemp. 3. Tetrahydrocannabinol is an aromatic with low water solubility.

Cannabis in the Community

These documents were created to support the work of the Coalition of Colorado Campus Alcohol and Drug Educators. We welcome prevention teams at

Objectives. 1. Review controversy 2. Pathophysiology 3. Indications for Use 4. Adverse Effects 5. How Patients Access

CDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only

Trichomes: Crystalline structures that coat parts of the cannabis plant that hold the majority of the cannabinoid content.

Important Information

Trends, Tactics and Toxicity: Marijuana Movement on Missouri College Campuses. Janice Putnam PhD, RN Amy Kiger MS, ABD Kelly Skinner DNP, FNP-C

The Scientific Side of Medical Marijuana

The Effects known & unknown of Marijuana in Older Adults. Danielle Fixen, PharmD, BCGP, BCPS University of Colorado School of Pharmacy

Marijuana. Marijuana (Cannabis Use Disorder) Learning Goals/Objectives

Learning Objectives 1/8/2019. Therapeutic Potential of the Marijuana-Derived Cannabinoids THC and CBD. Disclosures. Outline. Take home messages

CANNABIS FOR THE RHEUMATOLOGIST

Research on Cannabis and PD: Is there any evidence?

Rhode Island SUBSTANCE ABUSE PREVENTION United States Attorney Peter F. Neronha

WELCOME TO THEORY WELLNESS CUSTOMERS. Committed to wellbeing through cannabis.

Perkins Middle School

WELCOME TO THEORY WELLNESS PATIENTS. Committed to wellbeing through cannabis.

CANNABIS AND CANADA S CHILDREN AND YOUTH CPS Podcast

I would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people

MEDICAL MARIJUANA: WHAT S THE EVIDENCE?

Medicinal Cannabis. Patient Log Book. Record your cannabis use and find the right dose

Medical Cannabis MATT WEBSTER DO, MS

Federal Law: Marijuana

WHO Expert Committee on Drug Dependence Pre-Review: Cannabis plant and resin. Expert Peer Review 2

Year 9 Cannabis Quiz Answers and Background information

New Drugs of Abuse. Three Parts to US Federal Analog Act. Federal Analog Act (1986)

Steven G. Kinsey, PhD Associate Professor, Department of Psychology West Virginia University

Acknowledgements: What it is What it s not. Cannabis Evidence Series. Evidence-informed decision-making

Substances under Surveillance

Cannabis Use Disorder: What Nurses Need to Know. Bari K Platter, MS, RN, PMHCNS-BC Clinical Nurse Specialist

Synthetic cannabinoids: Flying high under the RADAR Brett Ginsburg, Ph.D.

The Sale of Cannabis in Pharmacies. Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association

CANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS

Cannabinoids (CB): Outline. CB: Epidemiology. CB: Categorization. CB: Pharmacodynamics. Part #1: Cannabinoid (CB) Primer.

Medical Marijuana Consent Form

AGENDA. 9:00 Sign-in and introductions 9:15 Marijuana 10:30 Break 10:45 Opioid Prevention 11:30 Discussion & Wrap-Up

Objectives. Why new drugs? New drugs of abuse: synthetic cannabinoids, stimulants, and 10/14/2015. Describe several new drugs of abuse

In order to do this we want a consistent approach from Sheffield agencies to maximise the impact of this work.

4/15/2019. US States with Marijuana Laws in Have ACOG and SMFM taken notice? THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION

Medical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center. Disclosure.

ADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP

a very bad combination

Medical Cannabis: A Patient Primer

Weeding Through the Science of Cannabis. Ryan Vandrey, PhD

Use of Cannabinoids in Medical Practice

Medicinal Cannabis Dosage Forms in California

Pennsylvania House of Representatives. Joint Health and Judiciary Committee Hearing. Medical Cannabis - Health Care Forum

MD GUIDE TO USING MEDICAL CANNABIS

Cannabis in the Workplace

39 th Expert Committee on Drug Dependence Process and recommendations

Medicinal cannabinoids where does it fit in Palliative Care? Janet Hardy Phillip Good Georgie Cupples Matthew Spitzer

Cannabidiol as a potential treatment for anxiety disorders. Esther Blessing, MD PhD

INITIAL PATIENT INTAKE FORM

Marijuana and the Chronic Non-Cancer Pain Patient

DESCRIPTION DURATION

Appendix 2: The nature and addictiveness of commonly used illicit drugs

9/28/2015. Support. R01CA A1 Intervening with smoking parents of inpatients to reduce

Legal, Designer or Synthetic MUST mean the drugs are safe. We do see drug related hospital admissions and deaths.

THC. A New Perspective

Marijuana and the Workplace : Changing Times

Cannabis Hyperemesis Syndrome: An Emerging Cause of Intractable Nausea & Vomiting

Controlled Substance and Wellness Agreement

POLICY NUMBER: POL 153

Novel Psychoactive Substances: Overview and Impact on Mental Health

Marijuana for Medical Use Patient Information

Cannabinoids. Effects of Cannabis

Is the most common illicit drug used in the United States. After a period of decline in the last decade, its use has been increasing among young

Marijuana in the Obstetric Population

James Donaldson CEO and Executive Director

Outcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

CANADIAN CANNABIS CRAZE (AND CONUNDRUM) Dr. Melissa Snider-Adler Chief Medical Review Officer DriverCheck Inc. Addiction Medicine Physician

Clinical Education Initiative MEDICAL MARIJUANA 101. Speaker: Patricia Reed, PharmD

CAPC/CPNP Coalition Face to Face Meeting October 18, 2018

Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD

Cannabis in the treatment of Autism:

PATIENT INTAKE FORM. Name: Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell:

WILL MARIJUANA LEGALIZATION INCREASE HOSPITALIZATIONS AND EMERGENCY ROOM VISITS?

Prescription Drug Abuse and Teens

9/13/2017. Marijuana and the Brain Matthew Wong, MD Assistant Professor, Department of Neurology, Epilepsy Section. Disclosures.

Ultimate Guide: Everything You Need To Know Before Buying CBD Hemp Oil

Marijuana for PTSD Among Veterans? Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Veterans Health Administration

Medical Marijuana. Navigating Medical Marijuana in Workers Compensation

PATIENT EDUCATION GUIDE

Puget Sound Educational Service District

Lisa Booze, PharmD, CSPI

CBD USER GUIDE CUREDNUTRITION.COM CBD INFUSED PRODUCTS MADE FROM COLORADO-GROWN ORGANIC HEMP

MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets

Information on Specific Drugs of Abuse

History of Medical Cannabis in Nursing

The Changing Face of Cannabis Culture. Marijuana Concentrates are Challenging Prevention Efforts. Prevention Leaders, Inc.

10 Questions to Ask. Before You Use Marijuana

Raritan Bay Medical Center

Live A Life Above The Influence!

Transcription:

Legalized Marijuana: Uses, Misuses & Abuses Kennon Heard University of Colorado SOM Dept Of Emergency Medicine Disclosures Research grants McNeil Consumer Healthcare (Acetaminophen) Rare Disease Therapeutics (Black Widow Spider) Royalties Up To Date (Acetaminophen Poisoning) Off label use of APM for vomiting Objectives At the end of this lecture you will be able to Describe the basic pharmacology of cannabis Recognize how route of exposure affects symptoms from exposure Identify marijuana products Treat common complications of marijuana use Interpret urine drugs screens for marijuana

Pharmacology Marijuana contains multiple active constituents Cannabinoid acids (THC) inactive Decarboxylated to the active phenols Decarboxylation occurs with heating Smoking Cooking Pharmacology Cannabinoids bind to CBD receptors CDB1 (CNS) and CBD 2 (Immune) Endocannabinoids are derived from arachadonic acid Effects vary with the specific cannabinoid concentrations present in each product Tetrahydrocannabinol ( )-trans-δ9-tetrahydrocannabinol (THC) Major psychoactive component of cannabis However > 30 substances in cannabis are active THC is a low affinity, partial agonist Doesn t bind tightly /does not fully activate vs. synthetic cannabinoids (Spice)

Cannabidiol (CBD) Up to 40% of cannabinoids in MJ May antagonize THC effects Popularized for treatment of pediatric epilepsy Charlotte s Web/Realm Oil FDA approved orphan drug Possibly used for MS Approved in Canada Medical MJ Per the Colorado constitution, recommended for : Cancer Glaucoma HIV or AIDS Chronic pain Seizures Chronic nausea Cachexia Persistent muscle spasms Emerging evidence for MS, Inflam BD, PTSD Routes of Exposure Smoked Inhaled (vaping) Vaporize without combustion Ingestion Dermal, rectal, injection

Dose 10mg of THC is roughly equivalent to the amount in a medium-sized joint 10 mg is the unit dose for edibles in Colorado Smoking Combust the plant product to volatilize the cannabinoids Joints Water pipe (bong) Inhalation - peak concentrations within minutes Easy to titrate Higher addiction potential? Carcinogens Smells like burning Vaping Heat marijuana until the THC is vaporized Lower temperature Does not combust (unlike smoking) Less THC destruction What to vape? Plant product THC fluids Hash oil

Vaporizing Temperature Cannabinoids volatilize at different temperature THC - 157 C. CBD - 160-180 C. Delta-8-THC - 175 178 C. CBN - 185 C. CBC - 220 C. THCV - 220 C. Plant product Vape fluids Soda Edibles Hashish Dronabinol What is out there Plant Products Most THC is in the flowers and leaves Less in stems 3% to 33% THC Hash resin made from trichomes Cannabinoid-rich glandular hairs Mechanical separation and pressed together THC content ranges from almost none to 70%

Ingestion More traditional medication profile may not peak for 6 hours Difficult to titrate Easier to overdose Edibles Colorado limits THC in edible pot products 10mg per serving Maximum of 10 servings per package Edibles must be sold in opaque, childproof containers that explicitly warn the product contains marijuana Cannot put it in commercial products Making Edibles

Organic extraction of cannabinoids from cannabis Plant products soaked in butane Heated to evaporate off solvent Hash Oil Hash Oil 30 to 95% cannabinoid Legal status of home cooking unclear until recently Now outlawed in Colorado Our burn unit has treated approximately 30 patients in the past 5 years for burns related to hash oil manufacturing Hash Oil

Dronabinol Synthetic THC Used for loss of appetite associated with weight loss in patients with AIDS and chemo nausea and vomiting 2.5, 5 and 10 mg tablets Not commonly abused Can be vaped Euphoria Dizziness Red eyes and dilated pupils Dry mouth Increased appetite Slowed reaction time A distorted sense of time Random thinking Effects Complications Intoxication medical complications occur rarely, if at all Now we see a few cases a week Too stoned to fly Anxiety Psychosis reported very rarely Not clear if it is an effect or unmasking underlying disease

Marijuana Hyperemesis 2004 Frequent (daily) use for months to years profusely vomit, sweating, colicky abdominal pain, and polydipsia..... take multiple hot baths or showers attempted to cope at home unless they exhausted their hot water supply or became debilitated by severe vomiting. At this point they would present to hospital Vomiting..refractory to the spectrum of antiemetic medication. Allen Gut 2004 Diagnostic Criteria Simonetto Mayo Clin Proc 2012 > 2 visits for vomiting without anatomic cause within 1 year 2 hospitals, 1 year pre and 1 post Rate of visits doubled after legalization Rate of having documented use tripled We did not find showering documented frequently

Management Initially most managed as usual abdominal pain IV fluids Opioid pain medications 5HT 3 antiemetics This led to frustration and admissions Our treatment of choice 5-10 mg iv with diphenhydramine Reviewing our outcomes Avoid opioids and benzodiazepines Sublingual olanzapine for outpt treatment? Promethazine may also work Withdrawal Previously dismissed as non-entity New designation in DSM 5 Estimated 10% of users become dependent (severe withdrawal syndrome) Most have only mild symptoms (except craving) Symptoms peak 1-3 days

DSM Criteria Cessation of cannabis use that has been heavy and prolonged (i.e., usually daily or almost daily use over a period of at least a few months). > 2 of the following Irritability, anger or aggression Nervousness or anxiety Sleep difficulty (i.e., insomnia, disturbing dreams) Decreased appetite or weight loss Restlessness Depressed mood At least one of the following physical symptoms causing significant discomfort: abdominal pain, shakiness/tremors, sweating, fever, chills, or headache Synthetic Cannabinoids Developed for medicinal use Now produced in China, Eastern Europe Specific compounds vary Compounds sprayed on plant products Sold as incense not for human consumption Initially legal due to definitions Many states have passed class regulation Synthetic Cannabinoids Bind to CBD receptors High affinity/high potency Clinical effects are not known until someone smokes it Not detected by routine urine drug screens Most exposures are unremarkable

General Effects Symptoms N=1,353 (%) Tachycardia 541 (40%) Agitation/irritability 317 (23.4%) Vomiting 207 (15.3%) Drowsiness/lethargy 183 (13.5%) Confusion 164 (12%) Nausea 139 (10%) Hallucination/delusion 127 (9.4%) Hypertension 110 (8.1%) Dizziness/vertigo 99 (7.3%) Chest pain 64 (4.7) Mamba 76 cases in 3 weeks to 2 ED s ADB-PINACA Altered mental status (67.6%) Agitation (42.1%), Seizures (14.4%). Intubation (12.7%) Bradycardia- 10% <50 BPM

Urine Drug Screen 11-nor-Δ 9 -THC-9-COOH Standard cutoff 50 ng/ml Specific for marijuana False positives are near impossible Assay specific Efavirenz, pantoprazole Cannot be positive from passive smoke If you are positive, you were high Summary Cannabis has complex pharmacology Eating delays onset and peak of symptoms New products and delivery more potent Intoxication rarely results in medical care Treat hyperemesis with APM Synthetics are unpredictable + is + on urine drug screen